Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
908,416
-
Shares change
-
+17,851
-
Total reported value, excl. options
-
$70,221,116
-
Value change
-
+$1,401,390
-
Number of buys
-
26
-
Number of sells
-
-26
-
Price
-
$77.33
Significant Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2021
98 filings reported holding PBE - INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY as of Q2 2021.
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 908,416 shares
.
Largest 10 shareholders include MORGAN STANLEY (153,374 shares), WELLS FARGO & COMPANY/MN (102,445 shares), ROYAL BANK OF CANADA (61,447 shares), OSAIC HOLDINGS, INC. (42,647 shares), BANK OF AMERICA CORP /DE/ (42,423 shares), LPL Financial LLC (38,383 shares), PFG Advisors (31,827 shares), UBS Group AG (29,805 shares), Anfield Capital Management, LLC (25,850 shares), and People's United Financial, Inc. (21,550 shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.